Population Pharmacokinetics and Exposure‐Safety Relationships of Alisertib in Children and Adolescents With Advanced Malignancies is a research paper published in The Journal of Clinical Pharmacology (2021). On theSindex it has a DataRank of 0.469. It has been cited 8 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.140
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
National Institutes of Health
Grant: 5UM1CA097452-13
Pediatric Phase 1/Pilot Consortium
National Institutes of Health
Grant: 2U10CA180899-06
Children's Oncology Group Statistics and Data Center
National Institutes of Health
Grant: 3U10CA180886-01S1
COG NCTN Network Group Operations Center
NCI NIH HHS
Grant: U10 CA180886
NCI NIH HHS
Grant: U10 CA180899
NCI NIH HHS
Grant: UM1 CA097452
FWCI
0.48
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals